Healthcare provider profile · identity verified

Marcos Omar Escobar, MD

Family Practice · FONTANA, CA · NPI 1821655481

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	525	235
Amlodipine Besylate	Amlodipine Besylate	272	112
Metformin Hcl	Metformin Hcl	263	99
Losartan Potassium	Losartan Potassium	244	97
Lisinopril	Lisinopril	223	86
Rosuvastatin Calcium	Rosuvastatin Calcium	206	84
Levothyroxine Sodium	Levothyroxine Sodium	172	65
Metformin Hcl Er	Metformin Hcl	169	65
Glipizide	Glipizide	158	58
Omeprazole	Omeprazole	148	70
Tamsulosin Hcl	Tamsulosin Hcl	138	59
Gabapentin	Gabapentin	120	47
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	119	44
Alendronate Sodium	Alendronate Sodium	104	41
Hydrochlorothiazide	Hydrochlorothiazide	99	39
Metoprolol Tartrate	Metoprolol Tartrate	89	35
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	85	26
Meloxicam	Meloxicam	80	50
Atenolol	Atenolol	78	28
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	74	27
Simvastatin	Simvastatin	67	25
Pantoprazole Sodium	Pantoprazole Sodium	65	23
Mirtazapine	Mirtazapine	63	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	60	24
Furosemide	Furosemide	59	36
Lactulose	Lactulose	59	17
Terazosin Hcl	Terazosin Hcl	49	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	20
Duloxetine Hcl	Duloxetine Hcl	47	22
Albuterol Sulfate Hfa	Albuterol Sulfate	46	30
Bisoprolol Fumarate	Bisoprolol Fumarate	46	20
Trazodone Hcl	Trazodone Hcl	46	24
Famotidine	Famotidine	43	20
Ibuprofen	Ibuprofen	43	28
Prednisone	Prednisone	40	36
Jardiance	Empagliflozin	38	13
Finasteride	Finasteride	36	17
Naproxen	Naproxen	35	13
Sertraline Hcl	Sertraline Hcl	35	12
Eliquis	Apixaban	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	32	19
Carvedilol	Carvedilol	31	14
Clopidogrel	Clopidogrel Bisulfate	31	13
Potassium Chloride	Potassium Chloride	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	14
Nifedipine Er	Nifedipine	30	suppressed
Spironolactone	Spironolactone	29	13
Pradaxa	Dabigatran Etexilate Mesylate	28	11
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	27	12
Humulin N Kwikpen	Insulin Nph Human Isophane	27	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	27	11
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	25	25
Arexvy	Rsvpref3 Antigen/As01e/Pf	24	24
Lovastatin	Lovastatin	24	suppressed
Ozempic	Semaglutide	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Terbinafine Hcl	Terbinafine Hcl	22	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	20
Hydrocortisone	Hydrocortisone	21	11
Benazepril Hcl	Benazepril Hcl	20	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	20	suppressed
Lidocaine	Lidocaine	19	16
Tramadol Hcl	Tramadol Hcl	19	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Cefadroxil	Cefadroxil	16	16
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Humulin N	Insulin Nph Human Isophane	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	13
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Clonazepam	Clonazepam	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	11
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error